Prognostic Significance of Methyl-p-Hydroxyphenyllactate-Esterase Activity in Laryngeal Cancer
Author Information
Author(s): M Maurizi, G Ferrandina, G Almadori, G Scambia, G Cadoni, G D'Agostino, FG Serra, M Piantelli, S Mancuso, FO Ranelletti
Primary Institution: Catholic University, Rome
Hypothesis
Does methyl-p-hydroxyphenyllactate esterase activity correlate with clinical outcomes in laryngeal squamous cell carcinoma?
Conclusion
High levels of methyl-p-hydroxyphenyllactate esterase activity are associated with better overall and relapse-free survival in laryngeal cancer patients.
Supporting Evidence
- 49% of patients experienced locoregional recurrences during the follow-up period.
- 43% of patients died of cancer by the end of the study.
- Cox univariate analysis showed that higher MeHPLAase activity was inversely associated with the risk of death and relapse.
Takeaway
This study found that patients with higher levels of a specific enzyme in their laryngeal cancer had a better chance of surviving and not having their cancer come back.
Methodology
The study analyzed methyl-p-hydroxyphenyllactate esterase activity in tumor samples from 63 untreated primary laryngeal squamous cell carcinoma patients and correlated it with clinical outcomes.
Limitations
The study was conducted at a single institution and may not be generalizable to all populations.
Participant Demographics
The study included 63 untreated consecutive primary laryngeal SCC patients, with a median follow-up of 50 months.
Statistical Information
P-Value
0.0124
Confidence Interval
60-97%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website